Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Pin1-mediated prolyl isomerization of Runx1 affects PU.1 expression in pre-monocytes.

Islam R, Yoon WJ, Woo KM, Baek JH, Ryoo HM.

J Cell Physiol. 2014 Apr;229(4):443-52. doi: 10.1002/jcp.24462.

PMID:
24037986
2.

Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.

Gu X, Hu Z, Ebrahem Q, Crabb JS, Mahfouz RZ, Radivoyevitch T, Crabb JW, Saunthararajah Y.

J Biol Chem. 2014 May 23;289(21):14881-95. doi: 10.1074/jbc.M114.562447. Epub 2014 Apr 2.

3.

RUNX1 regulates corepressor interactions of PU.1.

Hu Z, Gu X, Baraoidan K, Ibanez V, Sharma A, Kadkol S, Munker R, Ackerman S, Nucifora G, Saunthararajah Y.

Blood. 2011 Jun 16;117(24):6498-508. doi: 10.1182/blood-2010-10-312512. Epub 2011 Apr 25.

4.

Transcriptional regulation of human G2A in monocytes/ macrophages: involvement of c/EBPs, Runx and Pu.1.

Murakami N, Hashidate T, Harayama T, Yokomizo T, Shimizu T, Nakamura M.

Genes Cells. 2009 Dec;14(12):1441-55. doi: 10.1111/j.1365-2443.2009.01360.x. Epub 2009 Nov 20.

5.

PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.

Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z, Koschmieder S, Okuno Y, Dayaram T, Growney JD, Shivdasani RA, Gilliland DG, Speck NA, Nimer SD, Tenen DG.

Nat Genet. 2008 Jan;40(1):51-60. Epub 2007 Nov 11. Erratum in: Nat Genet. 2008 Feb;40(2):255.

PMID:
17994017
6.

Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.

Li X, Vradii D, Gutierrez S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Javed A.

J Cell Biochem. 2005 Nov 1;96(4):795-809.

PMID:
16149049
7.

The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.

Huang G, Zhao X, Wang L, Elf S, Xu H, Zhao X, Sashida G, Zhang Y, Liu Y, Lee J, Menendez S, Yang Y, Yan X, Zhang P, Tenen DG, Osato M, Hsieh JJ, Nimer SD.

Blood. 2011 Dec 15;118(25):6544-52. doi: 10.1182/blood-2010-11-317909. Epub 2011 Oct 19.

8.

The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis.

Hoogenkamp M, Krysinska H, Ingram R, Huang G, Barlow R, Clarke D, Ebralidze A, Zhang P, Tagoh H, Cockerill PN, Tenen DG, Bonifer C.

Mol Cell Biol. 2007 Nov;27(21):7425-38. Epub 2007 Sep 4.

9.

Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.

Zhou XZ, Lu PJ, Wulf G, Lu KP.

Cell Mol Life Sci. 1999 Nov 30;56(9-10):788-806. Review.

PMID:
11212339
10.

Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma.

Ito T, Nishiyama C, Nakano N, Nishiyama M, Usui Y, Takeda K, Kanada S, Fukuyama K, Akiba H, Tokura T, Hara M, Tsuboi R, Ogawa H, Okumura K.

Int Immunol. 2009 Jul;21(7):803-16. doi: 10.1093/intimm/dxp048. Epub 2009 Jun 5.

11.
12.

Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.

Nakatsu Y, Sakoda H, Kushiyama A, Zhang J, Ono H, Fujishiro M, Kikuchi T, Fukushima T, Yoneda M, Ohno H, Horike N, Kanna M, Tsuchiya Y, Kamata H, Nishimura F, Isobe T, Ogihara T, Katagiri H, Oka Y, Takahashi S, Kurihara H, Uchida T, Asano T.

J Biol Chem. 2011 Jun 10;286(23):20812-22. doi: 10.1074/jbc.M110.206904. Epub 2011 Mar 17.

13.

Prolyl isomerase Pin1 enhances osteoblast differentiation through Runx2 regulation.

Lee SH, Choi YH, Kim YJ, Choi HS, Yeo CY, Lee KY.

FEBS Lett. 2013 Nov 15;587(22):3640-7. doi: 10.1016/j.febslet.2013.09.040. Epub 2013 Oct 7.

14.

Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements.

Zarnegar MA, Chen J, Rothenberg EV.

Mol Cell Biol. 2010 Oct;30(20):4922-39. doi: 10.1128/MCB.00354-10. Epub 2010 Aug 9.

15.

The RUNX1-PU.1 axis in the control of hematopoiesis.

Imperato MR, Cauchy P, Obier N, Bonifer C.

Int J Hematol. 2015 Apr;101(4):319-29. doi: 10.1007/s12185-015-1762-8. Epub 2015 Mar 8. Review.

PMID:
25749719
16.

The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.

Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G.

Blood. 2003 Jan 1;101(1):270-7. Epub 2002 Aug 29.

17.

Pin1 and nuclear receptors: a new language?

La Montagna R, Caligiuri I, Giordano A, Rizzolio F.

J Cell Physiol. 2013 Sep;228(9):1799-801. doi: 10.1002/jcp.24316. Review.

PMID:
23280577
18.

Prolyl isomerase Pin1-mediated conformational change and subnuclear focal accumulation of Runx2 are crucial for fibroblast growth factor 2 (FGF2)-induced osteoblast differentiation.

Yoon WJ, Cho YD, Kim WJ, Bae HS, Islam R, Woo KM, Baek JH, Bae SC, Ryoo HM.

J Biol Chem. 2014 Mar 28;289(13):8828-38. doi: 10.1074/jbc.M113.516237. Epub 2014 Feb 7.

19.

Pin1-mediated Runx2 modification is critical for skeletal development.

Yoon WJ, Islam R, Cho YD, Woo KM, Baek JH, Uchida T, Komori T, van Wijnen A, Stein JL, Lian JB, Stein GS, Choi JY, Bae SC, Ryoo HM.

J Cell Physiol. 2013 Dec;228(12):2377-85. doi: 10.1002/jcp.24403.

20.

A critical step for JNK activation: isomerization by the prolyl isomerase Pin1.

Park JE, Lee JA, Park SG, Lee DH, Kim SJ, Kim HJ, Uchida C, Uchida T, Park BC, Cho S.

Cell Death Differ. 2012 Jan;19(1):153-61. doi: 10.1038/cdd.2011.82. Epub 2011 Jun 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk